10-K Decoder · All companies

Neurocrine Biosciences, Inc.

NBIX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$2.86B$2.36B+21.4%
Operating income$619M$570M+8.5%
Net income$479M$341M+40.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 2, 2026

$Q3 2026Year earlierChange
Revenue$1.12B$795M+41.2%
Operating income$331M$239M+38.6%
Net income$206M$210M−1.4%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Neurocrine's revenue in FY2025?
$2.86B in FY2025 (Fiscal year ended Dec 31, 2025), +21.4% vs $2.36B a year earlier, per its 10-K filed Feb 2026.
Was Neurocrine profitable in FY2025?
Yes: net income was $479M and operating income $619M in FY2025.
What was Neurocrine's revenue in Q3 2026?
$1.12B (+41.2% vs a year earlier), per its Form 10-Q filed Nov 2, 2026.